Zurcher Kantonalbank (Zurich Cantonalbank) - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 165 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2021. The put-call ratio across all filers is 0.68 and the average weighting 0.2%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$118,000
-9.9%
4,931
-45.0%
0.00%0.0%
Q4 2020$131,000
+50.6%
8,967
+47.0%
0.00%0.0%
Q3 2020$87,000
-3.3%
6,1020.0%0.00%0.0%
Q2 2020$90,000
+500.0%
6,102
+69.6%
0.00%
Q1 2020$15,000
-11.8%
3,5980.0%0.00%
Q4 2019$17,000
-22.7%
3,5980.0%0.00%
Q3 2019$22,000
-4.3%
3,5980.0%0.00%
Q2 2019$23,000
-11.5%
3,5980.0%0.00%
Q1 2019$26,000
+52.9%
3,5980.0%0.00%
Q4 2018$17,000
-34.6%
3,5980.0%0.00%
Q3 2018$26,000
+225.0%
3,598
+192.3%
0.00%
Q2 2018$8,000
+14.3%
1,2310.0%0.00%
Q1 2018$7,000
+40.0%
1,2310.0%0.00%
Q4 2017$5,000
-58.3%
1,2310.0%0.00%
Q3 2017$12,000
-20.0%
1,2310.0%0.00%
Q2 2017$15,000
-6.2%
1,2310.0%0.00%
Q1 2017$16,000
+6.7%
1,2310.0%0.00%
Q4 2016$15,0000.0%1,2310.0%0.00%
Q3 2016$15,000
+36.4%
1,2310.0%0.00%
Q2 2016$11,000
+83.3%
1,2310.0%0.00%
Q1 2016$6,000
-40.0%
1,2310.0%0.00%
Q4 2015$10,0000.0%1,2310.0%0.00%
Q3 2015$10,0001,2310.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,365,000$16,186,0001.49%
CADIAN CAPITAL MANAGEMENT, LP 5,517,767$26,540,0001.17%
NEEDHAM INVESTMENT MANAGEMENT LLC 1,590,000$7,646,0001.04%
Parkman Healthcare Partners LLC 420,000$2,020,0000.58%
Penn Capital Management Company, LLC 977,526$4,702,0000.49%
Bullseye Asset Management LLC 79,272$381,0000.37%
Bellevue Group AG 2,441,241$11,742,0000.19%
ESSEX INVESTMENT MANAGEMENT CO LLC 300,783$1,447,0000.18%
Granite Investment Partners, LLC 589,313$2,835,0000.13%
WRAPMANAGER INC 68,163$328,0000.10%
View complete list of GENMARK DIAGNOSTICS INC shareholders